33:22 | Jun 5th, 2018
In this episode, we interview Kathleen Lynch, PharmD and Ciantel (Adair) Blyler, PharmD, coauthors of the New England Journal of Medicine article, published in March 2018, investigating the role of pharmacist-led interventions for blood pressure redu...Show More
30:32 | May 15th, 2018
In this episode, we interview Janeen Winnike, Dean of the Office of Students Affairs at the RFUMS College of Pharmacy, regarding transitions from a student life to a practitioner life. With her previous role as an HR official within a large community...Show More
31:43 | Apr 24th, 2018
In this episode, we discuss five clinical pearls about pulmonary embolism ranging from PE diagnosis, classification, and treatment. We specifically examine when and how alteplase is given for PE and its use with concurrent anticoagulation.
36:06 | Apr 3rd, 2018
In this episode, we discuss two new agents (valbenazine and deutetrabenazine) -- the first of their kind to receive FDA approval to manage tardive dyskinesia most commonly associated with antipsychotic use.
20:26 | Mar 13th, 2018
In the previous episodes, we discussed how we should evaluate a patient’s bleeding and clotting risks as well as looked at recommendation for management for various anticoagulants. In this episode, we will continue the discussion to management of ant...Show More
31:07 | Feb 20th, 2018
In this episode, we will discuss some important factors to consider in management of various anticoagulants. We will also provide agent specific pharmacodynamic and pharmacokinetic based recommendations.
32:55 | Jan 30th, 2018
In this episode, we discuss the efficacy and safety of probiotics for the prevention of antibiotic-associated diarrhea (AAD) and Clostridium difficile-associated diarrhea (CDAD).
36:29 | Jan 9th, 2018
In this episode, we will review the surprising results of the VA/DoD's 2017 Clinical Practice Guidelines on Management of PTSD, particularly as it relates to the use of one particular agent, prazosin.
26:01 | Nov 28th, 2017
In this episode, we discuss the difficulty in identifying adverse drug reactions (ADR) that ACTUALLY occur from a drug therapy, how tertiary drug references (such as Micromedex or LexiComp) may be misleading, and what tips and tricks you can use to r...Show More
37:21 | Nov 7th, 2017
In this episode, we interview Dylan Moe, PharmD, our very own alumnus, regarding the new Illinois rule requiring patient counseling for all new prescriptions and inquire how the new rule has impacted his pharmacy, work environment, and his opinions o...Show More
35:58 | Oct 17th, 2017
In this episode, we will discuss the current state of benzodiazepine use, expected trends in prescribing, and risks associated with use. Lastly, we will discuss techniques for ensuring that a benzodiazepine taper is performed in a safe manner with lo...Show More
28:21 | Sep 26th, 2017
In this episode, we discuss new evidence for cardiovascular outcomes in diabetics based on the LEADER trial (liraglutide) and CANVAS trials (canagliflozin). We also discuss the new FDA warning for canagliflozin regarding amputation risk.
41:10 | Sep 5th, 2017
In this episode, we discuss updates in diabetes management that includes nuances from the ADA’s Standards of Care 2017. We also review some newer pharmacologic agents, a fixed dose GLP-1 agonist and basal insulin combinations.
33:23 | Aug 15th, 2017
In this episode, we discuss three "older" antihypertensives that are not preferred first-line therapies: clonidine, methyldopa, and minoxidil. We outline why these agents are not first-line therapies and review their pharmacology and adverse effect ...Show More
37:09 | Jul 4th, 2017
In this episode, we discuss several aspects of serotonin syndrome including the typical clinical presentation, its etiology and common drug-induced combinations, and how to appropriately manage the syndrome.
21:16 | Jun 13th, 2017
In this episode, we discuss the pathophysiology of embolic stroke in patients with atrial fibrillation and review the use of left atrial occlusion devices, such as the WATCHMAN device, to reduce the risk of stroke in patients with atrial fibrillation...Show More
33:27 | May 23rd, 2017
In this episode, we review the 12 recommendations from the 2016 CDC Guideline for Prescribing Opioids for Chronic Pain. These recommendations are intended to help curb the opioid epidemic and provide guidance to healthcare providers regarding safer ...Show More
27:03 | May 2nd, 2017
In this episode, we discuss the concept of professional advocacy, with a particular focus on how to advocate for the profession of pharmacy and what tools and organizations are available to assist in being an advocate.
37:51 | Apr 11th, 2017
In this episode, we discuss with Dr. Megan Hartranft the five oncology drugs that every pharmacist should know about, which is a great review for P4 students who are currently preparing for the NAPLEX. We cover cyclophosphamide, cisplatin, methotrex...Show More
25:27 | Mar 21st, 2017
In this episode, we discuss the newest definition of sepsis and septic shock according to the Sepsis-3 criteria and the 2016 Surviving Sepsis guidelines. We also review the scoring systems of “qSOFA” and “SOFA” and use a patient case to help demonst...Show More
28:52 | Feb 28th, 2017
In this episode, we discuss the overuse of proton pump inhibitor (PPI) therapy and several concerns regarding chronic use of this medication class, including hypomagnesemia, fracture risk, low seurm B12 levels, anemias, and increased risk of certain ...Show More
31:38 | Feb 7th, 2017
In this episode, we discuss the new FDA categorizations of biosimilars, the legal implications of biologic/biosimilar prescriptions, and the new "follow-on" approval pathway of Basaglar, a new insulin glargine U-100 product.
25:51 | Jan 17th, 2017
In this episode, we discuss the SPRINT trial (intensive vs. standard blood pressure control) using a case vignette of Mr. Wilson, a 55 year old patient presenting to a clinic with a blood pressure of 139/89 mmHg.
23:02 | Dec 6th, 2016
In this episode, we discuss more of the most important drug interactions, including grapefruit juice with statins and calcium channel blockers, QT prolonging medications, levothyroxine with cations and PPIs, and PDE-5 inhibitors with nitrates.
26:58 | Oct 4th, 2016
In this episode, we discuss three shocking recommendations from the CHEST 2016 VTE guideline update. We focus on (1) the debate between NOAC, DOAC, or TSOAC nomenclature, (2) the controversial recommendation of preferring NOACs over warfarin in VTE ...Show More
40:25 | Sep 13th, 2016
In this episode, we discuss RFUMS's Interprofessional Community Clinic (ICC), a student-run clinic providing health services to underserved populations. The students in this episode discuss how the ICC evolved and highlight pearls and challenges in ...Show More
41:00 | Aug 23rd, 2016
In this episode, we discuss the self-care of nasal congestion and allergies, including systemic/topical decongestants, nasal corticosteroids, antihistamines, cromolyn, and alternative medicine therapies.
33:57 | May 31st, 2016
In this episode, we discuss the science of carbohydrate-based sugars, sugar alcohols, artificial sweeteners, and natural sweeteners with Dr. Eric Walters, author of the book "The Sweetener Book" and Professor at Rosalind Franklin University.
29:11 | Jan 5th, 2016
In this episode, we have an in-depth review of how to measure glomerular filtration rate (GFR), including variants of the Cockcroft-Gault equation and newer, more accurate methods that may eventually be used to renally adjust certain medications.
38:14 | Mar 16th, 2015
In this episode, we review historical and new treatment options for hepatitis C, including: peginterferon, rivabirin, boceprevir, telaprevir, sofosbuvir (Sovaldi), simeprevir (Olysio), ombitasvir/paritaprevir/ritonavir/dasabuvir (Viekira Pak), and le...Show More
28:02 | Mar 3rd, 2015
In this episode, we discuss the pharmacology of oversedation, the importance of sedation minimization strategies in mechanically ventilated patients, and overview the sedatives and analgesics commonly used in this patient population.
22:52 | Nov 18th, 2014
In this episode, we discuss the management of overactive bladder, including: oxybutynin (Ditropan, Oxytrol), tolterodine (Detrol), trospium (Sanctura), solifenacin (VESIcare), darifenacin (Enablex), fesoterodine (Toviaz), mirabegron (Myrbetriq), and ...Show More
1:01:47 | Oct 21st, 2014
In this episode, we review a wide variety of cancer screening guidelines with a particular focus on the two most controversial screening areas: breast cancer screening with mammography and prostate cancer screening with PSA levels.
37:17 | Sep 23rd, 2014
In this episode, we discuss the new 2013 ACC/AHA obesity guidelines with a particular focus on three medications for obesity: lorcaserin (Belviq), phentermine/topiramate (Qsymia), and orlistat (Xenical, Alli).
27:18 | Jun 17th, 2014
In this episode, we discuss updates to the GOLD guidelines for COPD and review the newer agents for COPD including roflumilast (Daliresp), indacaterol (Arcapta Neohaler), aclidinium (Tudorza Pressair), umeclidinium/vilanterol (Anoro Ellipta), and flu...Show More
28:18 | Mar 5th, 2014
In this session of the RFUMS Top 200 Drugs Podcast, we discuss women’s health: conjugated estrogens, ethinyl estradiol, norethindrone, norgestrel, etonogestrel, medroxyprogesterone, raloxifene, tamoxifen, miconazole, Midol, phenazopyridine.
24:40 | Mar 5th, 2014
In this session of the RFUMS Top 200 Drugs Podcast, we discuss GI medications: methotrexate, allopurinol, mesalamine, esomeprazole, pantoprazole, rabeprazole, sucralfate, dicyclomine, simethicone, pyrantel, and lactase enzyme.
28:48 | Mar 5th, 2014
In this session of the RFUMS Top 200 Drugs Podcast, we discuss antiemetics, antitussives, and antihistamines: hydroxyzine, meclizine, metoclopramide, prochlorperazine, ondansetron, chlorpheniramine/hydrocodone, promethazine/codeine, desloratadine, di...Show More
27:26 | Mar 5th, 2014
In this session of the RFUMS Top 200 Drugs Podcast, we discuss muscle relaxants, stimulants, and anticonvulsants: baclofen, carisoprodol, metaxalone, cyclobenzaprine, methylphenidate, Adderall, lisdexamfetamine, phenytoin, divalproex, DEET, tolnaftat...Show More
18:53 | Mar 5th, 2014
In this session of the RFUMS Top 200 Drugs Podcast, we discuss antidepressants and antipsychotics: bupropion, venlafaxine, aripiprazole, quetiapine, risperidone, olanzapine, carbidopa/levodopa, pramoxine, Neosporin, and povidone/iodine.
19:27 | Mar 5th, 2014
In this session of the RFUMS Top 200 Drugs Podcast, we discuss antidepressants: citalopram, escitalopram, sertraline, fluoxetine, paroxetine, duloxetine, amitriptyline, trazodone, fexofenadine, oxymetazoline, and pheniramine.
22:12 | Mar 5th, 2014
In this session of the RFUMS Top 200 Drugs Podcast, we discuss sleep agents and neuropathic pain: alprazolam, clonazepam, diazepam, lorazepam, zolpidem, zaleplon, gabapentin, pregabalin, and lidocaine.
16:43 | Mar 5th, 2014
In this session of the RFUMS Top 200 Drugs Podcast, we discuss agents for COPD and asthma: albuterol, levalbuterol, ipratropium, tiotropium, albuterol/ipratropium, fluticasone, mometasone, fluticasone/salmeterol, and formoterol/budesonide.
16:53 | Mar 5th, 2014
In this session of the RFUMS Top 200 Drugs Podcast, we discuss antifungals and antivirals: fluconazole, itraconazole, ketoconazole, oseltamivir, acyclovir, valacyclovir, docosanol, terbinafine, and clotrimazole or miconazole.